Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill

被引:226
作者
Braun, Andrea [1 ]
Chang, Domingo [1 ]
Mahadevappa, Karthik [1 ]
Gibbons, Fiona K. [2 ]
Liu, Yan [3 ]
Giovannucci, Edward [3 ,4 ]
Christopher, Kenneth B. [1 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Div Renal, Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Div Pulm, Massachusetts Gen Hosp, Boston, MA 02115 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[4] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
VITAMIN-D DEFICIENCY; PROLONGED CRITICAL ILLNESS; MYOCARDIAL-INFARCTION; UNITED-STATES; ADMINISTRATIVE DATABASES; CARDIOVASCULAR-DISEASE; COMORBIDITY INDEX; OUTCOMES RESEARCH; CLINICAL-DATA; CO-MORBIDITY;
D O I
10.1097/CCM.0b013e318206ccdf
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: We hypothesized that deficiency in 25-hydroxyvitamin D before hospital admission would be associated with all-cause mortality in the critically ill. Design: Multicenter observational study of patients treated in medical and surgical intensive care units. Setting: A total of 209 medical and surgical intensive care beds in two teaching hospitals in Boston, MA. Patients: A total of 2399 patients, age >= 18 yrs, in whom 25-hydroxyvitamin D was measured before hospitalization between 1998 and 2009. Interventions: None. Measurements and Main Results: Preadmission 25-hydroxyvitamin D was categorized as deficiency in 25-hydroxyvitamin D (<= 15 ng/mL), insufficiency (16-29 ng/mL), and sufficiency (>= 30 ng/mL). Logistic regression examined death by days 30, 90, and 365 post-intensive care unit admission, in-hospital mortality, and blood culture positivity. Adjusted odds ratios were estimated by multivariable logistic regression models. Preadmission 25-hydroxyvitamin D deficiency is predictive for short-term and long-term mortality. At 30 days following intensive care unit admission, patients with 25-hydroxyvitamin D deficiency have an odds ratio for mortality of 1.69 (95% confidence interval of 1.28-2.23, p <. 0001) relative to patients with 25-hydroxyvitamin D sufficiency. 25-Hydroxyvitamin D deficiency remains a significant predictor of mortality at 30 days following intensive care unit admission following multivariable adjustment (adjusted odds ratio of 1.69, 95% confidence interval of 1.26-2.26, p < .0001). At 30 days following intensive care unit admission, patients with 25-hydroxyvitamin D insufficiency have an odds ratio of 1.32 (95% confidence interval of 1.02-1.72, p = .036) and an adjusted odds ratio of 1.36 (95% confidence interval of 1.03-1.79, p = .029) relative to patients with 25-hydroxyvitamin D sufficiency. Results were similar at 90 and 365 days following intensive care unit admission and for in-hospital mortality. In a subgroup analysis of patients who had blood cultures drawn (n = 1160), 25-hydroxyvitamin D deficiency was associated with increased risk of blood culture positivity. Patients with 25-hydroxyvitamin D insufficiency have an odds ratio for blood culture positivity of 1.64 (95% confidence interval of 1.05-2.55, p = .03) relative to patients with 25-hydroxyvitamin D sufficiency, which remains significant following multivariable adjustment (odds ratio of 1.58, 95% confidence interval of 1.01-2.49, p = .048). Conclusion: Deficiency of 25-hydroxyvitamin D before hospital admission is a significant predictor of short-and long-term all-cause patient mortality and blood culture positivity in a critically ill patient population. (Crit Care Med 2011; 39:671-677)
引用
收藏
页码:671 / 677
页数:7
相关论文
共 54 条
[1]   Vitamin D supplementation and total mortality - A meta-analysis of randomized controlled trials [J].
Autier, Philippe ;
Gandini, Sara .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (16) :1730-1737
[2]   DIFFERENTIAL-EFFECTS OF 1,25-DIHYDROXYVITAMIN D3 ON HUMAN-LYMPHOCYTES AND MONOCYTE MACROPHAGES - INHIBITION OF INTERLEUKIN-2 AND AUGMENTATION OF INTERLEUKIN-1 PRODUCTION [J].
BHALLA, AK ;
AMENTO, EP ;
KRANE, SM .
CELLULAR IMMUNOLOGY, 1986, 98 (02) :311-322
[3]   Vitamin D deficiency and susceptibility to tuberculosis [J].
Chan, TYK .
CALCIFIED TISSUE INTERNATIONAL, 2000, 66 (06) :476-478
[4]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[5]   Vitamin D: its role and uses in immunology [J].
Deluca, HF ;
Cantorna, MT .
FASEB JOURNAL, 2001, 15 (14) :2579-2585
[6]   ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619
[7]  
Eaton S, 2002, AM J RESP CRIT CARE, V165, pA471
[8]   REGULATION OF THE METABOLISM OF VITAMIN-D [J].
FRASER, DR .
PHYSIOLOGICAL REVIEWS, 1980, 60 (02) :551-613
[9]   Association Between Serum 25-Hydroxyvitamin D Level and Upper Respiratory Tract Infection in the Third National Health and Nutrition Examination Survey [J].
Ginde, Adit A. ;
Mansbach, Jonathan M. ;
Camargo, Carlos A., Jr. .
ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (04) :384-390
[10]   25-hydroxyvitamin D and risk of myocardial infarction in men - A prospective study [J].
Giovannucci, Edward ;
Liu, Yan ;
Hollis, Bruce W. ;
Rimm, Eric B. .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (11) :1174-1180